In vitro isolated tissue functional muscarinic receptor assays

Current Protocols in Pharmacology

Volumn , Issue SUPPL. 48, 2010, Pages

  Pulido Rios, M Teresa ^a   Steinfeld, Tod ^a   Armstrong, Scott ^a   Watson, Nikki ^a   Choppin, Agnes ^a   Eglen, Richard ^a   Hegde, Sharath S ^a  

^a Theravance California   (United States)

Author keywords

Basilar artery; Guinea pig ileum; Guinea pig trachea; Rabbit anococcygeus; Rat bladder; Rat duodenum; Saphenous vein

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; ATROPINE; CARBACHOL; HIMBACINE; LIGAND; METHOCTRAMINE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OXOTREMORINE; PIRENZEPINE; TRIPITRAMINE;

ANIMAL TISSUE; ANOCOCCYGEUS MUSCLE; BASILAR ARTERY; BINDING AFFINITY; BLADDER; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; DUODENUM; FEMALE; ILEUM; IN VITRO STUDY; ISOLATION PROCEDURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVIEW; SAPHENOUS VEIN;

EID: 77949413954     PISSN: 19348282     EISSN: 19348290     Source Type: Journal    
DOI: 10.1002/0471141755.ph0415s48     Document Type: Review

References (34)

1. Blinks, J.R., 1966. Field stimulation as a means of affecting the graded release of autonomic transmitters in isolated heart muscle. J. Pharmacol. Exp. Ther. 151: 221 - 235.
2. Caulfield, M.P., and, Birdsall, N.J.M., 1998. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 50: 279 - 290.
3. Chiarini, A., Budriesi, R., Bolognesi, M.L., Minarini, A., and, Melchiorre, C., 1995. In vitro characterization of tripitramine, a polymethylene tetraamine displaying high selectivity and affinity for muscarinic M2 receptors. Br. J. Pharmacol. 114: 1507 - 1517.
4. Clague, R.U., Eglen, R.M., Strachan, A.C., and, Whiting, R.L., 1985. Action of agonists and antagonists at muscarinic receptors present on ileum and atria in vitro. Br. J. Pharmacol. 86: 163 - 170.
5. Dorr, A., Sled, J.G., and, Kabani, N., 2007. Three-dimensional cerebral vasculature of the CBA mouse brain: A magnetic resonance imaging and micro computed tomography study. NeuroImage 35: 1409 - 1423.
6. Eglen, R.M., and, Harris, G.C., 1993. Selective inactivation of muscarinic M2 and M3 receptors in guinea-pig ileum and atria in vitro. Br. J. Pharmacol. 109: 946 - 952.
7. Eglen, R.M., and, Hegde, S.S., 1997. Muscarinic receptors and genitourinary smooth muscle function. In Muscarinic Receptor Subtypes in Smooth Muscle (, R.M. Eglen, ed.) pp. 149 - 160. CRC Press, New York.
8. Eglen, R.M., Montgomery, W.W., Dainty, I.A., Dubuque, L.K., and, Whiting, R.L., 1988. The interaction of methoctramine and himbacine at atrial, smooth muscle and endothelial muscarinic receptors in vitro. Br. J. Pharmacol. 95: 1031 - 1038.
9. Eglen, R.M., Michel, A.D., Montgomery, W.W., Kunysz, E.A., Machado, C.A., and, Whiting, R.L., 1990. The interaction of parafluorohexahydrosiladiphenidol at muscarinic receptors in vitro. Br. J. Pharmacol. 99: 637 - 642.
10. Eglen, R.M., Reddy, H., and, Watson, N., 1994. Selective inactivation of muscarinic receptor subtypes. Int. J. Biochem. 26: 1357 - 1368.
11. Eglen, R.M., Hegde, S.S., and, Watson, N., 1996a. Muscarinic receptor subtypes and smooth muscle function. Pharmacol. Rev. 48: 531 - 565.
12. Eglen, R.M., Pulido-Rios, M.T., Webber, A.P., Leung, E., and, Hegde, S.S., 1996b. Characterization of the interaction of darifenacin at muscarinic receptors subtypes in vitro. Br. J. Pharmacol. 118: 35P.
13. Fang, X., Faraci, F., Kaduce, T.L., Harmon, S., Modrick, M., Hu, S., Moore, S.A., Falck, J.R., Weintraub, N.L., and, Spector, A., 2006. 20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: Role of cyclooxygenase. Am. J. Physiol.Heart Circ. 291: H2301 - H2307.
14. Ford, A.P.D.W., Levine, W.B., Baxter, G.S., Harris, G.C., Eglen, R.M., and, Whiting, R.L., 1991. Pharmacological, biochemical and molecular characterization of muscarinic receptors in the guinea-pig ileum: A multidisciplinary study. Mol. Neuropharmacol. 1: 117 - 127.
15. Gilani, A.H., and, Cobbin, L.B., 1986. Cardio-selectivity of himbacine: A muscarine receptor antagonist. Naunyn-Schmiedebergs Arch. Pharmacol. 332: 16 - 20.
16. Gross, J., Augeli-Szafran, C.E., Czeche, S., Friebe, T., Jaen, J.C., Penvose-Yi, J.R., Schwarz, R.D., Mutschler, E., and, Lambrecht, G., 1997a. Functional characterization of PD 102807: The first M4-selective muscarinic antagonist. Life Sci. 60: 1168.
17. Gross, J., Mutschler, E., and, Lambrecht, G., 1997b. Evidence for muscarinic M4 receptors mediating nonadrenergic noncholinergic relaxations in rabbit anococcygeus muscle. N-S Arch. Pharmakol. 356: 505 - 516.
18. Hamrouni, A.M., Gudka, N., and, Broadley, K.J., 2006. Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors. Autonom. Autacoid. Pharmacol. 26: 275 - 284.
19. Hegde, S.S., Choppin, A., Bonhaus, D., Briaud, S., Loeb, M., Moy, T.M., Loury, D., and, Eglen, R.M., 1997. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. Br. J. Pharmacol. 120: 1409 - 1418.
20. Kenakin, T., 2003. A Pharmacology Primer: Theory, Application and Methods. Academic Press, San Diego.
21. Micheletti, R., Schiavone, A., and, Giachetti, A., 1988. Muscarinic M1 receptors stimulate a nonadrenergic noncholinergic inhibitory pathway in the isolated rat duodenum. J. Pharmacol. Exp. Ther. 244: 680 - 684.
22. Roffel, A.F., Hamstra, J.J., Elzinga, C.R., and, Zaagsma, J., 1994. Selectivity profile of some recent muscarinic antagonists in bovine and guinea-pig trachea and heart. Arch. Int. Pharmacodyn. Ther. 328: 82 - 98.
23. Roffel, A.F., Davids, J.H., Elzinga, C.R.S., Wolf, D., Zaagsma, J., and, Kilbinger, H., 1997. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic antagonist tripitramine. Br. J. Pharmacol. 122: 133 - 141.
24. Sagrada, A., Duranti, P., Giudici, L., and, Schiavone, A., 1994. Himbacine discriminates between putative muscarinic M1 receptor-mediated responses. Life Sci. 54: PL305 - PL310.
25. Watson, N., and, Eglen, R.M., 1994. Effects of muscarinic M2 and M3 receptor stimulation and antagonism on responses to isoprenaline of guinea-pig trachea in vitro. Br. J. Pharmacol. 112: 179 - 187.
26. Watson, N., Reddy, H., and, Eglen, R.M., 1995. Pharmacological characterization of the muscarinic receptor mediating contraction of canine saphenous vein. J. Autonom. Pharmacol. 15: 437 - 441.
27. Watson, N., Daniels, D.V., Ford, A.P., Eglen, R.M., and, Hegde, S.S., 1999. Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells. Br. J. Pharmacol. 127: 590 - 596.
28. Yamada, M., Lamping, K.G., Duttaroy, A., Zhang, W., Cui, Y., Bymaster, F.P., McKinzie, D.L., Felder, C.C., Deng, C., Faraci, F.M., and, Wess, J., 2001. Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice. Proc. Natl. Acad. Sci. U.S.A. 98: 14096 - 14101.
29. Blinks, 1966. See above. Provides an experimental protocol for guinea pig paced left atria.
30. Gross, et al., 1997a,b. See above. Characterization of the rabbit anococcygeus muscle as an M 4 preparation.
31. Hegde, 2006. See above. Provides a summary of the relevant in vitro data for common muscarinic receptor antagonists.
32. Hegde et al., 1997. See above. Characterization of the rat urinary bladder as an M 3 preparation.
33. Sagrada et al., 1994. See above. Comparison of the effects of himbacine (M 1 -discriminating antagonist) between known (superior cervical ganglia and canine saphenous vein) and proposed (rabbit vas deferens) M 1 preparations.
34. Watson, et al., 1995. See above. Antagonist affinity estimates for five key antagonists at the canine saphenous vein M 1 preparation.